- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Epimmune
Total 686 results
-
MedImmune LLCCompletedRespiratory Syncytial VirusUnited States, South Africa, Chile
-
MedImmune LLCCompletedMEDI3902 for Prevention of P. Aeruginosa PneumoniaUnited States
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedChronic Lung DiseaseUnited States
-
MedImmune LLCTerminatedRespiratory Syncytial VirusUnited States, Chile, South Africa, Canada, Estonia, Lithuania, Latvia
-
MedImmune LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
MedImmune LLCCompleted
-
MedImmune LLCTerminatedModerate AsthmaUnited Kingdom
-
MedImmune LLCCompletedAdvanced Solid Tumors | Advanced Recurrent Ovarian TumorsUnited States
-
MedImmune LLCCompletedAsthmaBulgaria, United Kingdom, Germany, Poland, Romania
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
MedImmune LLCCompletedRespiratory Syncytial Virus (RSV)United States
-
MedImmune LLCCompletedA Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With LupusLupus Erythematosus, Systemic | LupusUnited States
-
MedImmune LLCCompletedAllergic Rhinitis | Healthy Volunteers | Atopic Dermatitis | Allergic AsthmaUnited States
-
MedImmune LLCCompletedStaphylococcus AureusUnited States
-
MedImmune LLCTerminatedAsthmaUnited States, Canada
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedRespiratory Syncytial Virus Infections | Chronic Lung Disease and <= 24 Months of Age or | Premature With Gestational Age <=35 Weeks and <=6 Months of AgeAustralia, Chile, New Zealand
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedRespiratory Syncytial Virus Infections | Respiratory Viral Infections | Parainfluenza Virus 3, HumanUnited States
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedMalignant MelanomaUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedChronic Plaque PsoriasisCanada
-
Adimmune CorporationCompletedAdverse Drug Reactions
-
MedImmune LLCCompletedLymphoma | LeukemiaUnited States
-
MedImmune LLCCompletedRespiratory Syncytial Virus InfectionsUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedCancer | Graft-Versus-Host DiseaseUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
MedImmune LLCCompletedEsophagitis | Non-Small Cell Lung Carcinoma | PneumonitisUnited States
-
MedImmune LLCTerminatedLymphoma | Leukemia | CancerUnited States
-
MedImmune LLCCompletedSevere Respiratory DiseaseUnited States, Canada, Australia, Italy
-
MedImmune LLCCompletedPsoriasisUnited States
-
MedImmune LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Taiwan
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
NexImmune Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Evommune, Inc.CompletedAtopic Dermatitis EczemaUnited States
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
MedImmune LLCCompletedNeuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersUnited States, Czechia, Thailand, Germany, Korea, Republic of, Israel, New Zealand, Spain, Taiwan, Japan, Turkey, Hungary, Bulgaria, Mexico, Russian Federation, Colombia, Peru, Poland, Estonia, South Africa, Canada, Australia, Hong... and more
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedRSV Illness in ≤12 Months of ParticipantsUnited States, Chile, New Zealand, Australia, Panama
-
MedImmune LLCCompletedType 2 Diabetes MellitusNetherlands, Sweden
-
MedImmune LLCCompletedStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Japan
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France